Failure to transfer an analytical method or to move a process from lab to plant can cripple drug development efforts, wasting millions of dollars each year. Why do so many pharma tech transfer projects fail? How can one ensure their success, whether one is transferring to another department or to a contract manufacturing organization?
Join us for a controversial presentation and panel discussion of these issues on January 27, 2010, at 11 AM E.T. (8 AM P.T.) in the U.S.
Speakers include:
Stephen M. Perry, President, Kymanox
Russ Somma, President, Sommatech Consulting, LLC.
The program is sponsored by Tunnell Consulting and Patheon. To register, please visit: http://www.visualwebcaster.com/
